Enclosed please find the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026.
Kindly take the information on record.
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 27 May 2026, 08:34 PM IST · BSE ID: a20ec395-52c7-4abc-a1b4-27039845bad7
View Original BSE Filing (PDF)
💡
In Simple Terms
GKB Ophthalmics reported a loss of Rs. 356.79 Lakhs for the recent financial year, with lower sales.
🤖 AI Summary
- GKB Ophthalmics reported a standalone net loss of Rs. 356.79 Lakhs for the year ended March 31, 2026.
- Revenue from operations for the full fiscal year ended March 31, 2026, was Rs. 2,564.41 Lakhs.
- The total comprehensive loss for the year ended March 31, 2026, stood at Rs. 334.88 Lakhs.
- Basic and Diluted Earnings Per Share for FY26 were (Rs. 7.08) against (Rs. 12.12) in FY25.
- The company's total income for FY26 was Rs. 3,161.22 Lakhs, down from Rs. 3,472.16 Lakhs in FY25.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (FY26)
2,564.41 Rs. In Lakhs
Not comparable — limited prior period data.
Net Loss (FY26)
(356.79) Rs. In Lakhs
Not comparable — limited prior period data.
Basic EPS (FY26)
(7.08) Rs.
Not comparable — limited prior period data.
Total Income (FY26)
3,161.22 Rs. In Lakhs
Not comparable — limited prior period data.
Total Expenses (FY26)
3,346.72 Rs. In Lakhs
Not comparable — limited prior period data.
🏢 How This Affects the Company
Revenue from operations decreased to Rs. 2,564.41 Lakhs in FY26 from Rs. 3,274.94 Lakhs in FY25, indicating a contraction in core business sales.
The company recorded a net loss of Rs. 356.79 Lakhs in FY26, a reduction from the net loss of Rs. 610.79 Lakhs in FY25. Total expenses also decreased to Rs. 3,346.72 Lakhs from Rs. 4,075.79 Lakhs.
The sustained net loss and decrease in revenue indicate ongoing operational and financial challenges for the company.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the reported net loss of Rs. 356.79 Lakhs for the fiscal year.
🔍
Management Signal
The financial results signal management's efforts in cost control, demonstrated by reduced total expenses, despite a decline in operational revenue.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 results — monitor revenue from operations and profitability trends.
Next annual report — review detailed segment performance and management commentary.
Balance sheet updates — observe changes in assets and liabilities structure.
MEDIUM RISK
Sustained net losses and declining revenue indicate ongoing financial challenges for the company.
💡 Investor Takeaway
GKB Ophthalmics reported a standalone net loss of Rs. 356.79 Lakhs for the year ended March 31, 2026, a reduction from Rs. 610.79 Lakhs in FY25. Revenue from operations decreased to Rs. 2,564.41 Lakhs from Rs. 3,274.94 Lakhs. The company's total expenses also saw a reduction.
⚖️ Strengths & Concerns
✅ Positives
- Net loss for FY26 decreased to Rs. 356.79 Lakhs compared to a loss of Rs. 610.79 Lakhs in FY25, showing a reduction in losses.
- Total expenses for FY26 decreased to Rs. 3,346.72 Lakhs from Rs. 4,075.79 Lakhs in FY25, indicating cost management efforts.
⚠️ Concerns
- Revenue from operations decreased by Rs. 710.53 Lakhs to Rs. 2,564.41 Lakhs in FY26 from Rs. 3,274.94 Lakhs in FY25.
- The company continued to report a net loss for FY26, showing a lack of profitability in its operations.
❓ Frequently Asked Questions
What was GKB Ophthalmics' standalone net profit/loss for the year ended March 31, 2026?
GKB Ophthalmics reported a standalone net loss of Rs. (356.79) Lakhs for the year ended March 31, 2026.
What was GKB Ophthalmics' revenue from operations for the year ended March 31, 2026?
The revenue from operations for GKB Ophthalmics for the year ended March 31, 2026, was Rs. 2,564.41 Lakhs.
What were the Basic and Diluted Earnings Per Share for GKB Ophthalmics in FY26?
Basic and Diluted Earnings Per Share for GKB Ophthalmics were (Rs. 7.08) for the year ended March 31, 2026.
How did GKB Ophthalmics' total expenses compare between FY26 and FY25?
Total expenses for GKB Ophthalmics decreased to Rs. 3,346.72 Lakhs in FY26 from Rs. 4,075.79 Lakhs in FY25.
What was GKB Ophthalmics' total income for the year ended March 31, 2026?
GKB Ophthalmics reported a total income of Rs. 3,161.22 Lakhs for the year ended March 31, 2026.
Questions based on this BSE filing only. For information purposes.